Search
Search Results
##search.searchResults.foundPlural##
-
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1005PDF: 368HTML: 208 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3587PDF: 2514HTML: 1497 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3068PDF: 918HTML: 2043 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2299PDF: 1645HTML: 276 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1558PDF: 889HTML: 988figures: 188table 1: 189table2: 185table3: 190 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7661PDF: 2446HTML: 1740Table 1.: 215Table 2.: 226Table 3.: 210Table 4.: 210 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2638PDF: 1632HTML: 2373Table1: 195 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1590PDF: 401HTML: 217 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1138PDF: 503HTML: 243 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1567PDF: 799HTML: 214 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1644PDF: 595HTML: 233 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1386PDF: 855HTML: 139 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2150PDF: 1007HTML: 4079Cover Letter: 225Figure 1: 237Figure 2: 235Table 1: 207 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4410PDF: 1725HTML: 1045 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1420PDF: 828HTML: 3124 -
Skin Involvement in Primary Systemic Amyloidosis
1662PDF: 899HTML: 4384Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 184Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 158Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 180 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1871PDF: 729HTML: 2118Untitled: 225Untitled: 157Untitled: 177Untitled: 160Untitled: 169Untitled: 184Untitled: 191 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3990PDF: 1309HTML: 2274 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1529PDF: 554HTML: 744 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1314PDF: 477HTML: 18614Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2224PDF: 2057HTML: 199 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
847PDF: 831HTML: 131 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1247PDF: 537HTML: 230 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1199PDF: 768HTML: 1373Figure 1: 195Figure 2: 197







